<?xml version="1.0" encoding="UTF-8"?>
<p>Our data showed that ROS was generated in most brain regions, such as fore brain and tectum, in G3 zebrafish. ROS levels increased by 400% (t
 <sub>(14)</sub> = 4.236; 
 <italic>p</italic> &lt; 0.001, 
 <xref ref-type="fig" rid="ijms-22-01285-f005">Figure 5</xref>A), and survival rate decreased by 10% (t
 <sub>(4)</sub> = 9.000; 
 <italic>p</italic> &lt; 0.001, 
 <xref ref-type="fig" rid="ijms-22-01285-f005">Figure 5</xref>B) compared to G1, likely due to enhanced oxidative stress in zebrafish larvae. However, GM-90432 pretreatment prior to PTZ treatment suppressed ROS generation (t
 <sub>(14)</sub> = 4.483; 
 <italic>p</italic> &lt; 0.0005, 
 <xref ref-type="fig" rid="ijms-22-01285-f005">Figure 5</xref>B), and different concentrations of GM-90432 (2.5 to 10 Î¼M) increased survival rate in a dose-dependent manner (F
 <sub>(4, 10)</sub> = 42.13; 
 <italic>p</italic> = 0.0001, 
 <xref ref-type="app" rid="app1-ijms-22-01285">Figure S1</xref>) in zebrafish larvae. Therefore, our results suggest that GM-90432 has a neuroprotective effect against PTZ-induced oxidative stress and death via inhibition of ROS generation in zebrafish larvae.
</p>
